AzTrials
AzTrials

Negative-Pressure Wound TherapyNCT05716503

Comparison Between Negative Pressure Wound Therapy and Conventional Wound Dressings Before and After Split-Thickness Skin Grafting in Diabetic Foot Wounds

A study testing Negative Pressure Wound Therapy (NPWT) and Ordinary dressings with antibiotic ointment and gauze in people with Negative-Pressure Wound Therapy and Diabetic Foot, run by Sohag University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this thesis is to compare the efficacy of Vacuum assisted closure device versus conventional dressing before and after split thickness skin grafting in diabetic foot wounds. Read more about this study

Who is it for?
Ages 20 to 75 years
What is being tested?
Negative Pressure Wound Therapy (NPWT) and Ordinary dressings with antibiotic ointment and gauze
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
1 Feb 2023to Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age group 20-75 years.
  • Patients with diabetic foot wounds who are scheduled for skin grafting.

Who cannot join

  • Age <20 years or > 75 years.
  • An obvious septicemia.
  • Foot osteomyelitis.
  • Ulcer resulting from venous insufficiency.
  • Features of malignant ulcer.
  • Patients being treated with corticosteroids, immunosuppressive drugs.
  • Any other serious pre-existing cardiovascular, pulmonary or immunological disease.

Trial locations and contacts

1 site in 1 country.

Hady K Elhossiny, Resident contact

01096816840

dr_hady_94@yahoo.com

Gamal Y Elsayed, Professor contact

Egypt1 site, 1 recruiting
  • Sohag university hospital

    Sohag

    Hady K Elkhayat, Resident, dr.hady.94@gmail.com

    Recruiting

Other trials in Egypt

About this study

The aim of this thesis is to compare the efficacy of Vacuum assisted closure device versus conventional dressing before and after split thickness skin grafting in diabetic foot wounds.

Read the detailed description

Negative pressure wound therapy is a new noninvasive technique for treating open wounds. It works by removing fluid from the wound bed, reducing edema, and encouraging the growth and perfusion of new granulation tissue.

Vacuum-Assisted Closure device (VAC) helps to remove fluid from open wounds through a sealed dressing and tubing which is connected to a collection container. Vacuum-assisted closure (VAC) can provide stable and persistent negative pressure, and there are several modes to choose from.

VAC has played an important role in helping to close wounds, controlling infection, promoting angiogenesis, increasing blood flow, and promoting granulation tissue growth in wounds. It is now widely applied in all kinds of acute, chronic, and special wounds with good therapeutic results. However, there is a need to pay attention to contraindications and complications of VAC when it is used, avoiding secondary damage due to improper treatment.

Being tested
Negative Pressure Wound Therapy (NPWT), Ordinary dressings with antibiotic ointment and gauze
Medical subject headings
Diabetic Foot

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Negative Pressure Wound Therapy (NPWT)Device

    Patients Will Receive negative pressure wound therapy dressings before skin grafting to prepare the wound bed and after skin grafting.

  • Ordinary dressings with antibiotic ointment and gauzeOther

    Patients will Receive once daily dressing with antibiotic ointment and gauze before and after skin grafting.

Study groups in NCT05716503
Study groupRoleWhat they receive
Study group (A)ExperimentalStudy group (A): Will Receive negative pressure wound therapy dressings before skin grafting to prepare the wound bed and after skin grafting.
Receives: Device: Negative Pressure Wound Therapy (NPWT)
Control group (B)ExperimentalControl group (B): Will Receive once daily dressing with antibiotic ointment and gauze before and after skin grafting.
Receives: Other: Ordinary dressings with antibiotic ointment and gauze

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Period of hospitalization.

    Number of days of patient hospitalization before and after grafting

    Measured: 2 weeks

  2. Time of complete healing

    Number of days needed for each patient for complete healing after operation

    Measured: 1 month

  3. Functional outcome

    Number of patients with full range of mobility at site of graft Vs number of patients with limited mobility

    Measured: 5 months

  4. Patient satisfaction of aesthetic outcome

    Number of patients satisfied with the aesthetic result of the operation on a scale of 0-10

    Measured: 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2023
  2. Study start1 Feb 2023
  3. Primary completionFeb 2024 (estimated)
  4. Study completionApr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients will randomly be divided into two groups - study group and control group. Study group (A): Will Receive negative pressure wound therapy dressings before skin grafting to prepare the wound bed and after skin grafting. Control group (B): Will Receive once daily dressing with antibiotic ointment and gauze before and after skin grafting.
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05716503
Sponsor's protocol ID
Soh-Med-23-01-08
Status last verified
Apr 2023
First submitted
18 Jan 2023
Last updated
12 Apr 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Sinha K, Chauhan VD, Maheshwari R, Chauhan N, Rajan M, Agrawal A. Vacuum Assisted Closure Therapy versus Standard Wound Therapy for Open Musculoskeletal Injuries. Adv Orthop. 2013;2013:245940. doi: 10.1155/2013/245940. Epub 2013 Jun 26.

    PubMed 23878741
  • Lone AM, Zaroo MI, Laway BA, Pala NA, Bashir SA, Rasool A. Vacuum-assisted closure versus conventional dressings in the management of diabetic foot ulcers: a prospective case-control study. Diabet Foot Ankle. 2014 Apr 8;5. doi: 10.3402/dfa.v5.23345. eCollection 2014.

    PubMed 24765245
  • Ali Z, Anjum A, Khurshid L, Ahad H, Maajid S, Dhar SA. Evaluation of low-cost custom made VAC therapy compared with conventional wound dressings in the treatment of non-healing lower limb ulcers in lower socio-economic group patients of Kashmir valley. J Orthop Surg Res. 2015 Dec 10;10:183. doi: 10.1186/s13018-015-0314-5.

    PubMed 26654318
  • Ravari H, Modaghegh MH, Kazemzadeh GH, Johari HG, Vatanchi AM, Sangaki A, Shahrodi MV. Comparision of vacuum-asisted closure and moist wound dressing in the treatment of diabetic foot ulcers. J Cutan Aesthet Surg. 2013 Jan;6(1):17-20. doi: 10.4103/0974-2077.110091.

    PubMed 23723599

Questions about this trial

What is this clinical trial studying?

A study testing Negative Pressure Wound Therapy (NPWT) and Ordinary dressings with antibiotic ointment and gauze in people with Negative-Pressure Wound Therapy and Diabetic Foot, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hady K Elhossiny, Resident (01096816840, dr_hady_94@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Period of hospitalization. (time frame: 2 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05716503, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in